Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH

NCT07204041 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis (LCH)

Interventions

DRUG: Selinexor
DRUG: Thalidomide (100mg)
DRUG: Dexamethasone

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences